1Suppliers
6Customers
1Debt Items
0Related Chains

Source-Backed Evidence Depth

InflaRx N.V. (IFRX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

9Total relationships
1Distinct source URLs
3High confidence
0.716Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

InflaRx N.V. Suppliers

TickerNameConfidenceEvidence
THIRD-PARTY-MANUFACTURER-LOCATED-IN-CHINA THIRD-PARTY-MANUFACTURER-LOCATED-IN-CHINA 92% We engage a third-party manufacturer located in China for the clinical and commercial supply of the final drug product formulation of vilobelimab.

InflaRx N.V. Customers

TickerNameConfidenceEvidence
INFLARX-GMBH INFLARX-GMBH 62% ssets and discharge its liabilities in the normal course of business. These consolidated financial statements have been prepared on a going concern basis and do not include any adjustments to the car…
INFLARX-PHARMACEUTICALS-INC INFLARX-PHARMACEUTICALS-INC 62% parable or increasing net operating losses for the foreseeable future. Our net losses may fluctuate significantly from quarter to quarter and year to year. B. Financial operations overview A discussi…
IP-INFLARX-PHARMACEUTICALS-INC IP-INFLARX-PHARMACEUTICALS-INC 62% ssets and discharge its liabilities in the normal course of business. These consolidated financial statements have been prepared on a going concern basis and do not include any adjustments to the car…
LEERINK-PARTNERS-LLC LEERINK-PARTNERS-LLC 62% ct the price of our ordinary shares. Moreover, there can be no assurance that we will have sufficient financial or other resources to file and pursue such infringement claims, which typically last fo…
NASDAQ-STOCK-MARKET-LLC NASDAQ-STOCK-MARKET-LLC 62% ct the price of our ordinary shares. Moreover, there can be no assurance that we will have sufficient financial or other resources to file and pursue such infringement claims, which typically last fo…
SVB-LEERINK-LLC SVB-LEERINK-LLC 62% parable or increasing net operating losses for the foreseeable future. Our net losses may fluctuate significantly from quarter to quarter and year to year. B. Financial operations overview A discussi…

InflaRx N.V. Debt Obligations

InstrumentDescriptionConfidenceEvidence
IFRX-DEBT Debt stack $959,575 90% Market cache reports total debt of $959,575.

InflaRx N.V. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for InflaRx N.V..

InflaRx N.V. Ownership

HolderNameConfidenceEvidence
IFRX-OWNER-SUVRETTA-CAPITAL-MANAGEMENT-LLC SUVRETTA CAPITAL MANAGEMENT, LLC 90% 13F overlay lists SUVRETTA CAPITAL MANAGEMENT, LLC as top holder; 35 tracked holders.

InflaRx N.V. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.
🔐
IFRX
Unlock IFRX Supply Chain Data
Verified relationships include:
THIRD-PARTY-MANUFACTURER-LOCATED-IN-CHINATHIRD-PARTY-MANUFACTURER-…Supplier92%
INFLARX-GMBHINFLARX-GMBHCustomer62%
INFLARX-PHARMACEUTICALS-INCINFLARX-PHARMACEUTICALS-INCCustomer62%
+5 more relationships locked
Subscribe — View plans →